The TheraBionic P1 device has received European regulatory approval as a breakthrough medical product for unmet medical needs for the treatment of patients with advanced hepatocellular carcinoma who have either failed or are intolerant to first line and second line therapies.
https://www.therabionic.com/
December 06, 2018
view discussion